Related Experiment Video

Updated: Jul 5, 2025

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

12.5K

Molecular basis and current insights of atypical Rho small GTPase in cancer

Hua Huang1, Sijia Wang1, Yifei Guan1

  • 1Center of Excellence for Environmental Safety and Biological Effects, Faculty of Environment and Life, Beijing International Science and Technology Cooperation Base for Antiviral Drugs, Beijing University of Technology, Beijing, 100124, China.

Molecular Biology Reports
|January 18, 2024
PubMed

Insights

Atypical Rho GTPases, crucial for cell functions, are increasingly linked to human cancers. This review explores their molecular basis and roles in cancer development for new therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Atypical Rho GTPases are a diverse subfamily of Rho GTPases involved in cellular processes.
  • While typical Rho GTPases are well-researched, atypical Rho GTPases remain less explored but show significant potential.
  • Emerging evidence highlights their critical roles in human cancer development.

Purpose of the Study:

  • To review the molecular characteristics and biological functions of atypical Rho GTPases.
  • To explore the involvement and mechanisms of atypical Rho GTPases in various human cancers.
  • To provide insights for understanding cancer pathophysiology and developing novel therapeutic strategies.

Main Methods:

  • Literature review of current research on atypical Rho GTPases.
  • Summary of sequence characteristics, subcellular localization, and functions.
  • Analysis of recent advances in their roles in cancer development.

Main Results:

  • Atypical Rho GTPases exhibit diverse sequence features and subcellular localizations.
  • They regulate multiple biological processes, including those implicated in cancer.
  • Specific atypical Rho GTPases are associated with the development of various cancers.

Conclusions:

  • Atypical Rho GTPases are significant regulators in cellular functions and cancer progression.
  • Understanding their molecular mechanisms in tumors is crucial for cancer research.
  • Further exploration can lead to the development of targeted cancer therapies.
Keywords:
Atypical Rho GTPasesCancerCytoskeletonSmall GTPase

More Related Videos

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

9.9K
Comparing the Affinity of GTPase-binding Proteins using Competition Assays10:37

Comparing the Affinity of GTPase-binding Proteins using Competition Assays

Published on: October 8, 2015

9.2K

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.0K
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
2.7K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
8.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
3.9K